70. Association between serum inflammatory markers and autologous stem cell transplant-induced sickness symptoms in patients with multiple myeloma
β Scribed by Wang, X.; Shi, Q.; Shah, N.; Dantzer, R.; Johnson, V.; Reubenl, J.; Cohen, E.; Ilagan, V.; Williams, L.; Cleeland, C.
- Book ID
- 122402957
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 39 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0889-1591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Highβdose therapy and autologous stem cell transplant (HDT) have been shown to prolong survival in multiple myeloma (MM) in randomized trials, but only included patients of 65 years or younger. Given the median age at diagnosis of 66 years, it is important to have a better understanding
## Abstract Dickkopfβ1 (DKKβ1) protein, a soluble inhibitor of Wnt signalling, has been implicated in the pathogenesis of myeloma bone disease through the suppression of osteoblast differentiation. In this study, serum concentrations of DKKβ1 were measured in 50 myeloma patients (32 at diagnosis an
Six pts had progressive disease, two pts died in infections (1. Candida tropicalis pneumonia caused fatal pulmonary bleeding on day +8; 2. in another case a multiorgan failure developed after Enterococcus sepsis on day +115). Follow up time is 28 months (1 78), 12/17 pts are in complete remission (C